BackAIM ImmunoTech Overview

AIM ImmunoTech Current Cash

Track AIM ImmunoTech's current cash ($9.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.90M
↑ 1979.83% YoYΔ $9.42M vs prior year quarter

Peer trimmed avg / median

Loading

AIM ImmunoTech Current Cash History

Loading

AIM ImmunoTech vs. peers: Current Cash Comparison

Loading

AIM ImmunoTech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AIM ImmunoTech (AIM) FAQ

The latest current cash for AIM is $9.9M as of June 2026. That compares with $480K in the prior-year period — up 1979.8% year over year. Investors often review this figure alongside AIM ImmunoTech's historical trend and sector peers before judging valuation or financial health.

Over the past year, AIM's current cash moved from $480K to $9.9M — a 1979.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AIM ImmunoTech's operating scale or balance-sheet position.

A current cash figure of $9.9M for AIM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AIM's current cash ($9.9M), review year-over-year change from $480K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AIM ImmunoTech's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.